Identification of a population of epidermal squamous cell carcinoma cells with enhanced potential for tumor formation
- PMID: 24376802
- PMCID: PMC3869846
- DOI: 10.1371/journal.pone.0084324
Identification of a population of epidermal squamous cell carcinoma cells with enhanced potential for tumor formation
Abstract
Epidermal squamous cell carcinoma is among the most common cancers in humans. These tumors are comprised of phenotypically diverse populations of cells that display varying potential for proliferation and differentiation. An important goal is identifying cells from this population that drive tumor formation. To enrich for tumor-forming cells, cancer cells were grown as spheroids in non-attached conditions. We show that spheroid-selected cells form faster growing and larger tumors in immune-compromised mice as compared to non-selected cells. Moreover, spheroid-selected cells gave rise to tumors following injection of as few as one hundred cells, suggesting these cells have enhanced tumor-forming potential. Cells isolated from spheroid-selected tumors retain an enhanced ability to grow as spheroids when grown in non-attached culture conditions. Thus, these tumor-forming cells retain their phenotype following in vivo passage as tumors. Detailed analysis reveals that spheroid-selected cultures are highly enriched for expression of epidermal stem cell and embryonic stem cell markers, including aldehyde dehydrogenase 1, keratin 15, CD200, keratin 19, Oct4, Bmi-1, Ezh2 and trimethylated histone H3. These studies indicate that a subpopulation of cells that possess stem cell-like properties and express stem cell markers can be derived from human epidermal cancer cells and that these cells display enhanced ability to drive tumor formation.
Conflict of interest statement
Figures








Similar articles
-
Spheres derived from the human SN12C renal cell carcinoma cell line are enriched in tumor initiating cells.J Exp Clin Cancer Res. 2016 Oct 18;35(1):163. doi: 10.1186/s13046-016-0442-8. J Exp Clin Cancer Res. 2016. PMID: 27756344 Free PMC article.
-
Melanoma spheroids grown under neural crest cell conditions are highly plastic migratory/invasive tumor cells endowed with immunomodulator function.PLoS One. 2011 Apr 15;6(4):e18784. doi: 10.1371/journal.pone.0018784. PLoS One. 2011. PMID: 21526207 Free PMC article.
-
Tumor initiating cells: development and critical characterization of a model derived from the A431 carcinoma cell line forming spheres in suspension.Cell Cycle. 2010 Mar 15;9(6):1194-206. doi: 10.4161/cc.9.6.11108. Epub 2010 Mar 15. Cell Cycle. 2010. PMID: 20237414
-
Tumor-initiating properties of breast cancer and melanoma cells in vivo are not invariably reflected by spheroid formation in vitro, but can be increased by long-term culturing as adherent monolayers.Int J Cancer. 2013 Feb 1;132(3):E94-105. doi: 10.1002/ijc.27785. Epub 2012 Sep 7. Int J Cancer. 2013. PMID: 22907275
-
Tumor-derived spheroids: Relevance to cancer stem cells and clinical applications.Cancer Sci. 2017 Mar;108(3):283-289. doi: 10.1111/cas.13155. Cancer Sci. 2017. PMID: 28064442 Free PMC article. Review.
Cited by
-
NRP-1 interacts with GIPC1 and SYX to activate p38 MAPK signaling and cancer stem cell survival.Mol Carcinog. 2019 Apr;58(4):488-499. doi: 10.1002/mc.22943. Epub 2018 Dec 21. Mol Carcinog. 2019. PMID: 30456845 Free PMC article.
-
Telomere DNA damage signaling regulates cancer stem cell evolution, epithelial mesenchymal transition, and metastasis.Oncotarget. 2017 Sep 16;8(46):80139-80155. doi: 10.18632/oncotarget.20960. eCollection 2017 Oct 6. Oncotarget. 2017. PMID: 29113290 Free PMC article.
-
Cancer Stem Cells in Squamous Cell Carcinoma.J Invest Dermatol. 2017 Jan;137(1):31-37. doi: 10.1016/j.jid.2016.07.033. Epub 2016 Nov 24. J Invest Dermatol. 2017. PMID: 27638386 Free PMC article. Review.
-
Metformin overcomes metabolic reprogramming-induced resistance of skin squamous cell carcinoma to photodynamic therapy.Mol Metab. 2022 Jun;60:101496. doi: 10.1016/j.molmet.2022.101496. Epub 2022 Apr 9. Mol Metab. 2022. PMID: 35405370 Free PMC article.
-
The transglutaminase 2 cancer cell survival factor maintains mTOR activity to drive an aggressive cancer phenotype.Mol Carcinog. 2023 Jan;62(1):90-100. doi: 10.1002/mc.23446. Epub 2022 Jul 18. Mol Carcinog. 2023. PMID: 35848131 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials